Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades
about
Ameliorative effects of lutein on non-alcoholic fatty liver disease in ratsHepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
P2860
Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Transitions of histopathologic ...... during the last three decades
@ast
Transitions of histopathologic ...... during the last three decades
@en
Transitions of histopathologic ...... during the last three decades
@nl
type
label
Transitions of histopathologic ...... during the last three decades
@ast
Transitions of histopathologic ...... during the last three decades
@en
Transitions of histopathologic ...... during the last three decades
@nl
prefLabel
Transitions of histopathologic ...... during the last three decades
@ast
Transitions of histopathologic ...... during the last three decades
@en
Transitions of histopathologic ...... during the last three decades
@nl
P2860
P356
P1476
Transitions of histopathologic ...... during the last three decades
@en
P2093
Yoshihiro Ikura
P2860
P304
P356
10.4254/WJH.V6.I12.894
P407
P577
2014-12-27T00:00:00Z